IDENTIFICATION OF EFFICIENT PENTAPEPTIDE SUBSTRATES FOR THE TYROSINE KINASE PP60(C-SRC)

被引:30
作者
NAIR, SA
KIM, MH
WARREN, SD
CHOI, S
ZHOU, SY
CANTLEY, LC
HANGAUER, DG
机构
[1] SUNY BUFFALO, SCH PHARM, DEPT MED CHEM, BUFFALO, NY 14260 USA
[2] BETH ISRAEL HOSP, DEPT MED, DIV SIGNAL TRANSDUCT, BOSTON, MA 02215 USA
[3] HARVARD UNIV, SCH MED, DEPT CELL BIOL, BOSTON, MA 02215 USA
关键词
D O I
10.1021/jm00021a017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The development of inhibitors of protein tyrosine kinases (PTKs) is a promising approach to obtaining new therapeutic agents for a variety of diseases, particularly cancer. However, the discovery of peptide-based inhibitors has been hindered by the lack of small peptide substrate sequences (i.e. five residues or less) with which a variety of inhibitor designs could be readily evaluated by replacing the Tyr with natural and unnatural amino acids. These prototypical small peptide inhibitors could then form the basis for designing analogous conformationally constrained, peptide-mimetic or non-peptide inhibitors with improved therapeutic potential. In this study we have identified the best known small peptide substrate for the PTK pp60(c-src) which is the parent of the src family of nonreceptor PTKs. This pentapeptide substrate, Ac-Ile-Tyr-Gly-Glu-Phe-NH2, has a K-m of 368 mu M and V-max of 1.02 mu mol/min/mg when tested utilizing the assay methodology of Budde et al. (Anal. Biochem. 1992, 200, 347-351) after a series of modifications were made to more closely simulate the conditions inside a typical mammalian cell. This substrate was designed from information obtained by Songyang et al. (Nature 1995, 373, 536-539) with a 2.5 billion member combinatorial library of peptide substrates for pp60(c-src). A second pentapeptide substrate, Ac-Glu-Asp-Ala-Ile-Tyr-NH2, with a weaker binding affinity (K-m = 880 mu M) but improved V-max (1.86 mu mol/min/mg), was also identified. This peptide was designed from the pp60(c-src) autophosphorylation sequence and information obtained by Songyang et al. (Ibid.) and Till et al. (J. Biol. Chem. 1994, 269, 7423-7428) with combinatorial libraries of peptide substrates. These new substrates provide sufficient binding affinities and rates of phosphorylation to be utilized for evaluating the relative effectiveness of various reversible and mechanism-based irreversible inhibitor designs for pp60(c-src) while appended to easily prepared small peptides.
引用
收藏
页码:4276 / 4283
页数:8
相关论文
共 66 条
[1]   DIVALENT METAL-IONS INFLUENCE CATALYSIS AND ACTIVE-SITE ACCESSIBILITY IN THE CAMP-DEPENDENT PROTEIN-KINASE [J].
ADAMS, JA ;
TAYLOR, SS .
PROTEIN SCIENCE, 1993, 2 (12) :2177-2186
[2]  
Alberts B. D., 1989, MOL BIOL CELL, P301
[3]  
BARNEKOW A, 1987, CANCER RES, V47, P235
[4]  
BJELFMAN C, 1990, CANCER RES, V50, P6908
[5]  
BOLEN JB, 1987, ONCOGENE RES, V1, P149
[6]   ACTIVATION OF PP60C-SRC PROTEIN-KINASE ACTIVITY IN HUMAN-COLON CARCINOMA [J].
BOLEN, JB ;
VEILLETTE, A ;
SCHWARTZ, AM ;
DESEAU, V ;
ROSEN, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2251-2255
[7]   TYROSINE PROTEIN-KINASE INHIBITION AND CANCER [J].
BOUTIN, JA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1994, 26 (10-11) :1203-1226
[8]   BOUND AND DETERMINED - A COMPUTER-PROGRAM FOR MAKING BUFFERS OF DEFINED ION CONCENTRATIONS [J].
BROOKS, SPJ ;
STOREY, KB .
ANALYTICAL BIOCHEMISTRY, 1992, 201 (01) :119-126
[9]   AN ASSAY FOR ACIDIC PEPTIDE-SUBSTRATES OF PROTEIN-KINASES [J].
BUDDE, RJA ;
MCMURRAY, JS ;
TINKER, DA .
ANALYTICAL BIOCHEMISTRY, 1992, 200 (02) :347-351
[10]  
BURKE T R JR, 1992, Drugs of the Future, V17, P119